Rett Syndrome: Why It Predominantly Affects Girls (X-Linked Genetics)
Rett syndrome is an X-linked dominant neurodevelopmental disorder caused by MECP2 mutations. It overwhelmingly affects females.
Genetic Basis
- Gene: MECP2 (Xq28) — encodes methyl-CpG-binding protein 2, regulates gene expression.
- Inheritance: >99% de novo mutations; rarely inherited from germline mosaic parent.
- Male lethality: Males (46,XY) lack a second X → no functional MECP2 → severe neonatal encephalopathy, death <2 years (rare survivors: Klinefelter 47,XXY or somatic mosaicism).
- Female survival: Random X-inactivation → mosaic expression → variable severity.
Incidence
- Females: ~1 in 10,000–15,000 live births.
- Males: ~1 in 500,000 (only with 47,XXY or mosaicism).
Clinical Features (Females)
- Normal development 6–18 mo → regression (loss of speech, hand use, gait).
- Stereotypic hand movements (wringing, washing).
- Seizures, breathing abnormalities, scoliosis, growth failure.
Variable Expressivity
X-inactivation skewing, mutation type (missense vs. truncating), and modifiers cause wide severity range. Some females mildly affected.
Management
- Multidisciplinary: neurology, orthopedics, GI, pulmonology, PT/OT/ST.
- Trofinetide (FDA-approved 2023) modestly improves symptoms.
- Gene therapy trials underway.
Genetic Disorders - Related Articles
- Understanding Traits: Genetics, Inheritance & Characteristics
- Hereditary Diseases: Inherited vs. Spontaneous Mutations
- Living with Neurofibromatosis Type 1 (NF1): Lifespan & Outlook
- Syndrome, Karyotype, and Pedigree: Definitions and Differences in Genetics
- Lifestyle Diseases vs. Hereditary Diseases: Key Differences & Prevention
- Understanding Genetic Diseases: Types, Causes & Impact
- PCOS and Pregnancy: Effects on Fetal Development and Long-Term Health
